FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2050966129> ?p ?o ?g. }

• W2050966129 endingPage "1085" @default.
• W2050966129 startingPage "1081" @default.
• W2050966129 abstract "Pyriform sinus squamous cell carcinoma (SCC) has one of the worst prognoses of all upper aerodigestive tract cancers. Improving clinical outcomes for patients with hypopharyngeal SCC has been particularly challenging for head and neck surgeons and oncologists.We investigated 30 patients with pyriform sinus SCC to verify the effectiveness of weekly cisplatin chemotherapy with concurrent radiotherapy. Cisplatin was administered at a dose of 40 mg/m(2) on weeks 1, 2, 3, 5, 6, and 7 during definitive radiotherapy with the aim of preserving the larynx.All 30 patients achieved definitive radiotherapy at a median dose of 70 Gy (range 64-70 Gy). Cisplatin was administrated concomitantly a median of five times (range 2-6 times). Persistent or recurrent primary disease was observed in four patients (13 %). Persistent or recurrent nodal metastasis was observed in five patients (17 %). Nine salvage surgeries were performed for eight patients, of whom seven survived without any evidence of disease. Post-operative complications were observed in two patients (22 %). The 5-year overall survival and locoregional control rates were 87 and 96 %, respectively. The 5-year laryngeal preservation rate was 74 %.The regimen of weekly cisplatin CRT may be effective for pyriform sinus SCC; however, there were problems with strong selection bias in the current study due to the large number of T2 patients. Salvage surgery was safe and was able to improve the survival rate. This chemoradiation regimen was considered successful in preserving laryngeal function." @default.
• W2050966129 created "2016-06-24" @default.
• W2050966129 creator A5003497147 @default.
• W2050966129 creator A5005371127 @default.
• W2050966129 creator A5020774876 @default.
• W2050966129 creator A5026356023 @default.
• W2050966129 creator A5027961713 @default.
• W2050966129 creator A5028998584 @default.
• W2050966129 creator A5045604410 @default.
• W2050966129 creator A5054540480 @default.
• W2050966129 creator A5061496996 @default.
• W2050966129 creator A5066514747 @default.
• W2050966129 creator A5069964997 @default.
• W2050966129 creator A5088707584 @default.
• W2050966129 date "2015-03-25" @default.
• W2050966129 modified "2023-10-16" @default.
• W2050966129 title "Clinical outcomes of weekly cisplatin chemoradiotherapy for patients with pyriform sinus cancer" @default.
• W2050966129 cites W2022395184 @default.
• W2050966129 cites W2036005555 @default.
• W2050966129 cites W2100961085 @default.
• W2050966129 cites W2102465568 @default.
• W2050966129 cites W2111442242 @default.
• W2050966129 cites W2120404243 @default.
• W2050966129 cites W2122252223 @default.
• W2050966129 cites W2123266829 @default.
• W2050966129 cites W2125919881 @default.
• W2050966129 cites W2129273621 @default.
• W2050966129 cites W2171249454 @default.
• W2050966129 doi "https://doi.org/10.1007/s10147-015-0821-8" @default.
• W2050966129 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25804347" @default.
• W2050966129 hasPublicationYear "2015" @default.
• W2050966129 type Work @default.
• W2050966129 sameAs 2050966129 @default.
• W2050966129 citedByCount "3" @default.
• W2050966129 countsByYear W20509661292017 @default.
• W2050966129 countsByYear W20509661292018 @default.
• W2050966129 countsByYear W20509661292019 @default.
• W2050966129 crossrefType "journal-article" @default.
• W2050966129 hasAuthorship W2050966129A5003497147 @default.
• W2050966129 hasAuthorship W2050966129A5005371127 @default.
• W2050966129 hasAuthorship W2050966129A5020774876 @default.
• W2050966129 hasAuthorship W2050966129A5026356023 @default.
• W2050966129 hasAuthorship W2050966129A5027961713 @default.
• W2050966129 hasAuthorship W2050966129A5028998584 @default.
• W2050966129 hasAuthorship W2050966129A5045604410 @default.
• W2050966129 hasAuthorship W2050966129A5054540480 @default.
• W2050966129 hasAuthorship W2050966129A5061496996 @default.
• W2050966129 hasAuthorship W2050966129A5066514747 @default.
• W2050966129 hasAuthorship W2050966129A5069964997 @default.
• W2050966129 hasAuthorship W2050966129A5088707584 @default.
• W2050966129 hasBestOaLocation W20509661292 @default.
• W2050966129 hasConcept C121608353 @default.
• W2050966129 hasConcept C126322002 @default.
• W2050966129 hasConcept C141071460 @default.
• W2050966129 hasConcept C143998085 @default.
• W2050966129 hasConcept C2776283816 @default.
• W2050966129 hasConcept C2776341189 @default.
• W2050966129 hasConcept C2776530083 @default.
• W2050966129 hasConcept C2776694085 @default.
• W2050966129 hasConcept C2778239845 @default.
• W2050966129 hasConcept C2778424827 @default.
• W2050966129 hasConcept C2778474501 @default.
• W2050966129 hasConcept C2779196318 @default.
• W2050966129 hasConcept C2780140570 @default.
• W2050966129 hasConcept C2780474809 @default.
• W2050966129 hasConcept C2780775027 @default.
• W2050966129 hasConcept C2781413609 @default.
• W2050966129 hasConcept C2908917430 @default.
• W2050966129 hasConcept C509974204 @default.
• W2050966129 hasConcept C71924100 @default.
• W2050966129 hasConceptScore W2050966129C121608353 @default.
• W2050966129 hasConceptScore W2050966129C126322002 @default.
• W2050966129 hasConceptScore W2050966129C141071460 @default.
• W2050966129 hasConceptScore W2050966129C143998085 @default.
• W2050966129 hasConceptScore W2050966129C2776283816 @default.
• W2050966129 hasConceptScore W2050966129C2776341189 @default.
• W2050966129 hasConceptScore W2050966129C2776530083 @default.
• W2050966129 hasConceptScore W2050966129C2776694085 @default.
• W2050966129 hasConceptScore W2050966129C2778239845 @default.
• W2050966129 hasConceptScore W2050966129C2778424827 @default.
• W2050966129 hasConceptScore W2050966129C2778474501 @default.
• W2050966129 hasConceptScore W2050966129C2779196318 @default.
• W2050966129 hasConceptScore W2050966129C2780140570 @default.
• W2050966129 hasConceptScore W2050966129C2780474809 @default.
• W2050966129 hasConceptScore W2050966129C2780775027 @default.
• W2050966129 hasConceptScore W2050966129C2781413609 @default.
• W2050966129 hasConceptScore W2050966129C2908917430 @default.
• W2050966129 hasConceptScore W2050966129C509974204 @default.
• W2050966129 hasConceptScore W2050966129C71924100 @default.
• W2050966129 hasIssue "6" @default.
• W2050966129 hasLocation W20509661291 @default.
• W2050966129 hasLocation W20509661292 @default.
• W2050966129 hasLocation W20509661293 @default.
• W2050966129 hasOpenAccess W2050966129 @default.
• W2050966129 hasPrimaryLocation W20509661291 @default.
• W2050966129 hasRelatedWork W2027500168 @default.
• W2050966129 hasRelatedWork W2029344511 @default.
• W2050966129 hasRelatedWork W2090243293 @default.

• next